Idarubicin Hydrochloride

盐酸伊达比星

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIdarubicin Hydrochloride
Drug Alias Name盐酸去甲氧柔红霉素Idarubicine盐酸依达比星Zavedos Oral伊达比星 +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsLeukemia, Myeloid, AcuteNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1990/09/27
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesAntibioticos SpaPfizer Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01DB06
Related LinksWikipediaDrugBankKEGG